Position in BIIB
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$74,027,124
+$15,717,918 QoQ
Shares Held
342,623
+7.7% QoQ
Ownership
0.232%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#52
of 1,036 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in BIIB Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026FIL Ltd holds $2,310,187,043 across 11 Drug Manufacturers - General names. BIIB ranks #9 (3.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
4,492,612 | $851,889,084 | |
| 2 | BMY |
Bristol Myers Squibb Co
|
6,523,813 | $375,902,104 | |
| 3 | PFE |
Pfizer Inc
|
10,482,713 | $252,423,729 | |
| 4 | LLY |
ELI LILLY & Co
|
201,889 | $242,151,742 | |
| 5 | ABBV |
AbbVie Inc.
|
677,123 | $170,391,231 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
987,104 | $124,710,718 | |
| 7 | JNJ |
Johnson & Johnson
|
431,712 | $109,641,896 | |
| 8 | MRK |
Merck & Co., Inc.
|
678,957 | $87,245,974 |
All Filings in BIIB
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $74,027,124 | 342,623 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $58,309,206 | 318,056 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $56,236,548 | 319,544 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $43,144,219 | 307,997 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $30,685,655 | 244,332 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $16,420,800 | 120,000 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $16,013,323 | 104,717 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $37,993,027 | 196,002 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $183,278,049 | 790,605 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $151,461,099 | 702,412 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $169,883,021 | 656,502 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $16,280,040 | 63,344 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $18,226,412 | 63,986 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $17,762,502 | 63,887 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $15,236,969 | 55,023 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $13,957,692 | 52,276 | Shares | Defined | 2022-11-10 | |
| 2022-03-31 | $14,382,084 | 68,291 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $17,434,025 | 72,666 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $21,054,455 | 74,400 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $26,594,573 | 76,803 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $26,250,900 | 93,837 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $19,510,444 | 79,680 | Shares | Defined | 2021-03-23 | |
| 2020-09-30 | $312,048 | 1,100 | Shares | Defined | 2020-11-13 | |
| 2020-03-31 | $11,959,796 | 37,802 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||